An instrument that quickly and more effectively analyzes complex biological and environmental samples was today named one of the past year's 100 most significant scientific and technological products or advances. The innovation was recognized by R&D Magazine in their annual R&D 100 Awards competition.
While the use of ultrasound to identify tumors during kidney cancer surgery is gaining acceptance, a research team at Henry Ford Hospital has successfully taken it a step further by showing an added benefit when the procedure is done robotically.
Next-generation hydrogels can form synthetic scaffolds to support the formation of replacement tissues and organs in the emerging area of regenerative medicine. Embedding peptides into the hydrogels stimulates the growth of essential microvascular networks to ensure a good blood supply.
In a study reported in the July 1, 2013 Angewandte Chemie, a group of University of Illinois bioengineers have found a way to strongly adhere hydrogels to hydrophobic silicone substrates, an innovation that provides a valuable new tool for microscale biotechnology.
Milestone Scientific Inc., a leading medical research and development company that designs and patents innovative injection technology, announced today that it has entered into a strategic partnership with Tri-anim Health Services, Inc., the nation’s largest provider of specialty sales and distribution solutions for healthcare, with core competencies in respiratory medicine, anesthesia, NICU, ICU and the OR.
The MDT 2013/2014 Buyers' Guide features a comprehensive directory that includes an array of technology and service categories that are critical to the designers and manufacturers of medical devices.
Consumer-driven user requirements for home-use devices increasingly require more than just usability, safety, and efficacy; strong insight into why the consumer needs the device is also required. From backyard sheds to universities and research groups to small and large companies alike, bright minds have no shortage of invention of medical products designed for home use.
X2 Biosystems, a medical device company that's developing sensors for sports brain injuries, drummed up $3.3 million of a hoped-for $12.5 million raise, according to a regulatory filing. Eighteen unnamed investors kicked in on the round, according to the filing.
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that its ANCHOR post-market registry enrollment has surpassed its key milestone of 250 patients.
Since its launch last month, House Majority Leader Eric Cantor's (R-Va.) Citizen Cosponsor website has listed nearly 3,000 bills, among them "Protect Medical Innovation Act of 2013," a measure to repeal the 2.3% medical device tax that took effect at the start of this year.
Spinal Elements, a spine technology company, today announced that spine surgeon Scott H. Kitchel, MD of Eugene, Oregon recently presented data on the company's Ti-Bond® porous titanium coated polyetheretherketone (PEEK) interbody devices at the Spine Technology and Educational Group meeting held June 20-22 in Los Cabos, Mexico.
Inspired by studies demonstrating canine abilities to sniff out cancerous biomarkers, a team of U.K. researchers developed a scent-analysis device that they say can diagnose early signs of bladder cancer. In a test of nearly 100 urine samples, the device, called OdorReader, was 100% accurate in distinguishing which samples came from cancer patients.
Surefire Infusion System Found Safe and Effective for Delivery of 90Y in Treating Inoperable Liver CancerJuly 10, 2013 6:00 am | by PR Newswire | News | Comments
Case reports published in the Journal of Cardiovascular and Interventional Radiology found that by using the Surefire Infusion System, radioembolization could be successfully performed without the need to protect nearby blood vessels, a significant advance that may enable doctors to safely extend liver cancer treatment to patients who were previously deemed untreatable.
Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of the CardioChek® family of point-of-care diagnostic products, has announced the issuance of two new U.S. patents. U.S. Patent No. 8,257,654 relates to the management of health data collected by point-of-care testing devices using a health report server. U.S. Patent No. 8,307,531 covers a method and apparatus for manufacturing disposable dry test strips.
Halt Medical Announces New CPT® Code From the American Medical Association for RF Ablation of Uterine FibroidsJuly 10, 2013 3:00 am | by PR Newswire | News | Comments
Halt Medical is very pleased to announce that the American Medical Association (AMA) Current Procedure Terminology (CPT) Panel has established a new CPT® code specifically for Radiofrequency (RF) Ablation of Uterine Fibroids. CPT codes are used by medical practitioners; including physicians, hospitals, and other healthcare providers to report healthcare services to insurers for the purpose of reimbursement.